- 全部删除
您的购物车当前为空
Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5)是一种抗小鼠/人/大鼠的CCL2/MCP-1的单克隆抗体,能够阻断CCL2信号通路,逆转免疫抑制微环境,提高化疗敏感性,减少巨噬细胞的浸润,抑制潜在HIV播种,可用于研究炎症疾病,病毒感染和癌症,如炎症性肠病 (IBD)和肝细胞癌 (HCC)。
Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5)是一种抗小鼠/人/大鼠的CCL2/MCP-1的单克隆抗体,能够阻断CCL2信号通路,逆转免疫抑制微环境,提高化疗敏感性,减少巨噬细胞的浸润,抑制潜在HIV播种,可用于研究炎症疾病,病毒感染和癌症,如炎症性肠病 (IBD)和肝细胞癌 (HCC)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 747 | In stock | |
| 5 mg | ¥ 2,980 | In stock | |
| 10 mg | ¥ 4,970 | 2-4周 |
Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) 相关产品
| 产品描述 | Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) is a monoclonal antibody targeting mouse/human/rat CCL2/MCP-1, capable of blocking the CCL2 signalling pathway, reversing the immunosuppressive microenvironment, enhancing chemotherapy sensitivity, reducing macrophage infiltration, and inhibiting latent HIV seeding. It is applicable for studying inflammatory diseases, viral infections, and cancers such as inflammatory bowel disease (IBD) and hepatocellular carcinoma (HCC). |
| 体外活性 | Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5) (5 μg/mL)处理 16 小时后,THP-1细胞向受感染的肠样源性单层(EDM)的迁移显著减少[1]。 |
| 体内活性 | 在 DEN 和 CCl4 诱导的肝细胞癌模型中,联合使用 Anti-Mouse/Rat/Human CCL2/MCP-1 Antibody (2H5)(8 mg/kg,腹腔注射,每周4次,第18-24周)与 BLZ945,可使肿瘤数量显著减少[4]。 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
评论内容